Cancer News
Articles 31 - 40 of most recent articles
Cancer Drug Delivery Research At Case Western Reserve University Cuts Time From Days To Hours
Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems. Using laboratory mice, drug delivery time from injection to the cancer cells was reduced from two days to mere hours.
Medical News Today – Jul 23, 2008 12:00 PM [GMT] ¦ comment?
Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems. Using laboratory mice, drug delivery time from injection to the cancer cells was reduced from two days to mere hours.
Medical News Today – Jul 23, 2008 12:00 PM [GMT] ¦ comment?
End Of Life Physician-Patient Communication: Ensuring Final Chapter Is Enacted With The Greatest Skill And Compassion Possible
Although a growing body of research supports a link between effective communication and patient, family and physician satisfaction, doctors, including oncologists and other specialists who frequently care for terminal patients, do not routinely receive training in end-of-life conversations during medical school, residency training, or after they start to practice medicine.
Medical News Today – Jul 23, 2008 11:00 AM [GMT] ¦ comment?
Although a growing body of research supports a link between effective communication and patient, family and physician satisfaction, doctors, including oncologists and other specialists who frequently care for terminal patients, do not routinely receive training in end-of-life conversations during medical school, residency training, or after they start to practice medicine.
Medical News Today – Jul 23, 2008 11:00 AM [GMT] ¦ comment?
First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Providing Worldwide Customers With A Single Source Solution For Cancer Treatment Rooms
Veritas Medical Solutions, LLC has been formed to provide worldwide customers with a single source solution for cancer treatment rooms. Focused on providing innovative modular designs, products and services, the company provides all the pieces necessary for a rapid, turnkey therapy room installation.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Veritas Medical Solutions, LLC has been formed to provide worldwide customers with a single source solution for cancer treatment rooms. Focused on providing innovative modular designs, products and services, the company provides all the pieces necessary for a rapid, turnkey therapy room installation.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
MIMA Cancer Center First In World To Treat Soft Tissue Carcinoma With Stereotactic Body Radiotherapy Using RapidArc™ Radiotherapy Technology
Doctors at Melbourne Internal Medical Associates (MIMA) Cancer Center have become the first in Florida to treat cancer using RapidArc™ radiotherapy technology from Varian Medical Systems (NYSE: VAR). They are also the first in the world to use this technology to deliver stereotactic body radiotherapy (SBRT) in the treatment of soft tissue carcinoma.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Doctors at Melbourne Internal Medical Associates (MIMA) Cancer Center have become the first in Florida to treat cancer using RapidArc™ radiotherapy technology from Varian Medical Systems (NYSE: VAR). They are also the first in the world to use this technology to deliver stereotactic body radiotherapy (SBRT) in the treatment of soft tissue carcinoma.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Intervention Delivered By Nurses Can Help Combat Depression In Cancer Patients
A team of Scottish researchers have shown that cancer patients offered a depression care intervention - delivered by specially trained oncology nurses with no previous psychiatric experience - showed improvements in symptoms of depression compared to patients offered usual care. The beneficial effects of the "Depression Care for People with Cancer" package (DCPC) were found to be sustained at 12 months follow-up, to the surprise of the investigators.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
A team of Scottish researchers have shown that cancer patients offered a depression care intervention - delivered by specially trained oncology nurses with no previous psychiatric experience - showed improvements in symptoms of depression compared to patients offered usual care. The beneficial effects of the "Depression Care for People with Cancer" package (DCPC) were found to be sustained at 12 months follow-up, to the surprise of the investigators.
Medical News Today – Jul 23, 2008 10:00 AM [GMT] ¦ comment?
Cancer Molecular Diagnostics: On The Critical Path To Personalized Medicine
The Healthcare practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American cancer molecular diagnostics market to be held on Thursday July 24, 2008 at 10:00 a.m. PDT. The presentation will cover strategic insight into the U.S. cancer molecular diagnostics market and how the market correlates with growth in the world of personalized medicine.
Medical News Today – Jul 23, 2008 09:00 AM [GMT] ¦ comment?
The Healthcare practice at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the North American cancer molecular diagnostics market to be held on Thursday July 24, 2008 at 10:00 a.m. PDT. The presentation will cover strategic insight into the U.S. cancer molecular diagnostics market and how the market correlates with growth in the world of personalized medicine.
Medical News Today – Jul 23, 2008 09:00 AM [GMT] ¦ comment?
Plants Make Vaccine For Treating Type Of Cancer, Stanford Study
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
Medical News Today – Jul 23, 2008 09:00 AM [GMT] ¦ comment?
Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
Medical News Today – Jul 23, 2008 09:00 AM [GMT] ¦ comment?
Research Identifies Best Way To Discover If Cancer Has Spread
For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests - until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.
Medical News Today – Jul 23, 2008 08:00 AM [GMT] ¦ comment?
For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests - until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.
Medical News Today – Jul 23, 2008 08:00 AM [GMT] ¦ comment?
Unnecessary Biopsies Reduced By Team Work, SLU Researchers Find
Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.
Medical News Today – Jul 23, 2008 08:00 AM [GMT] ¦ comment?
Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.
Medical News Today – Jul 23, 2008 08:00 AM [GMT] ¦ comment?
